Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers

This module will introduce learners to the American Society of Clinical Oncology (ASCO) guideline summary on managing chemotherapy-induced peripheral neuropathy in survivors of adult cancers.

Learning Objectives

After completing this self-paced free training, you will be able to:

  • Identify chemotherapy agents associated with neuropathy in adult patients with cancer and associated symptoms
  • Describe strategies to prevent chemotherapy-induced peripheral neuropathy
  • Describe strategies to treat chemotherapy-induced peripheral neuropathy that develops during or after neurotoxic chemotherapy
Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 0.50 Completion
Course opens: 
04/26/2023
Course expires: 
04/08/2028
Part of: 
Cancer Survivorship Care Guidelines for Peripheral Neuropathy, Fertility Preservation and Osteoporosis Management

Guido Cavaletti, MD

University of Milano-Bicocca

School of Medicine and Surgery

PHYSICIANS 

The George Washington University School of Medicine and Health Sciences designates this activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. 

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 0.50 Completion
Please login or register to take this course.